Skip to main content
OpenTrials
Completed

NCT Number: NCT04404608

Etiology of Lymphopenia in Covid19 Infection

Study of the cause of lymphopenia in Covid19 viral infection will be done in 3 cohorts. First cohort will be patients asymptomatic or with mild symptoms. Second cohort will be patients with severe illness and admitted to ICU. Third cohort will be patients critically ill and on artificial ventilation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lymphopenia Cytopenia Hematologic Diseases Hemic and Lymphatic Diseases Immune System Diseases Immunologic Deficiency Syndromes Leukocyte Disorders Leukopenia

Sex eligibility

All sexes

Study type

Observational

Primary location

National Cancer Institute Cairo University

Cairo, Egypt

About this study

Each cohort will include 30 patients. Complete blood count in all patients will be done daily in all patients. Bone marrow aspiration cytology will be done in some selected patients especially those with lymphopenia less than 1000 per cubic mm.

Correlation of the degree of lymphopenia with the status of the patients will be done. Also correlation will be done about the relation of recovery of lymphopenia and status of the patients.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any patient admitted with the diagnosis of Covid19 viral infection

Exclusion criteria

  • Any patient who died within one day of admission

Treatment and study plan

Complete blood picture, bone marrow aspiration cytology

Diagnostic Test

none except the regular routine investigations in such cases

Primary outcomes

  1. Death or recovery

    Time frame: Up to 24 weeks

    Follow up

Sponsors and collaborators

Lead sponsor

Dr Medhat Khafagy

Other

Registry information

Official study title

Study of the Etiology of Lymphopenia in Covid19 Viral Infection

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
May 27, 2020
Registry last updated
Jul 20, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.